Related Experiment Video
Updated: Jun 3, 2025
Measurement of the Pressure-volume Curve in Mouse Lungs
Published on: January 27, 2015
Impact of corticosteroids on improving lung compliance in a patient with pulmonary microscopic polyangiitis
Mason Motakef1, Gautam Sikka2, Jennifer Ma3
1The University of Texas Health Science Center at Houston, Houston, Texas, USA mason.r.motakef@uth.tmc.edu.
Abstract:
Microscopic polyangiitis (MPA) is a small-vessel vasculitis characterised by systemic infiltration, with a primary focus on the renal and pulmonary systems. One of its more lethal pulmonary manifestations is diffuse alveolar haemorrhage (DAH), although the spectrum of lung pathology in MPA is vast and calls for immediate immunosuppressive therapy. Our case looks at an older woman initially presenting with MPA-induced rapid progressive glomerulonephritis. However, she gradually develops an array of vasculitis-related pulmonary insults that necessitate endotracheal intubation, and following a short course of immunosuppression, her lungs undergo a rapid physiological recovery. This case highlights that induction therapy with steroids enhances lung compliance and results in a more profound respiratory recovery in ventilated MPA patients who lack DAH-related pulmonary symptoms.
Insights
Microscopic polyangiitis (MPA) can cause severe lung issues. Early steroid treatment in ventilated MPA patients without diffuse alveolar hemorrhage significantly improves respiratory recovery and lung function.
Area of Science:
- Rheumatology
- Pulmonology
- Nephrology
Background:
- Microscopic polyangiitis (MPA) is a small-vessel vasculitis primarily affecting the kidneys and lungs.
- Diffuse alveolar hemorrhage (DAH) is a critical pulmonary complication of MPA requiring prompt immunosuppression.
Observation:
- An elderly female patient presented with MPA-induced rapidly progressive glomerulonephritis.
- She subsequently developed various pulmonary complications necessitating mechanical ventilation.
- Following initial immunosuppressive therapy, her pulmonary function rapidly improved.
Findings:
- The patient's lung compliance improved with steroid induction therapy.
- This led to enhanced respiratory recovery in the ventilated MPA patient.
- The patient did not exhibit DAH-related pulmonary symptoms.
Implications:
- Early steroid therapy is crucial for improving lung compliance in ventilated MPA patients.
- This approach can lead to better respiratory outcomes in MPA cases without DAH.
- Highlights the importance of comprehensive management of MPA's diverse pulmonary manifestations.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids